Optimizing Dual-Time and Serial Positron Emission Tomography and Single Photon Emission Computed Tomography Scans for Diagnoses and Therapy Monitoring
暂无分享,去创建一个
[1] Wolfgang A Weber,et al. Time course of tumor metabolic activity during chemoradiotherapy of esophageal squamous cell carcinoma and response to treatment. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] Abass Alavi,et al. Dual time point 18F-FDG PET for the evaluation of pulmonary nodules. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] T. Shibasaki,et al. Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[4] T. Saga,et al. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer. , 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[5] H. Sakahara,et al. Delayed 18F‐fluoro‐2‐deoxy‐D‐glucose positron emission tomography scan for differentiation between malignant and benign lesions in the pancreas , 2000, Cancer.
[6] I. Sesterhenn,et al. Localization of primary prostate cancer with dual-phase 18F-fluorocholine PET. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] M. Hata,et al. FDG-PET scanning after radiation can predict tumor regrowth three months later. , 2003, International journal of radiation oncology, biology, physics.
[8] P. Sinha,et al. Narrow time-window dual-point 18F-FDG PET for the diagnosis of thoracic malignancy , 2003, Nuclear medicine communications.
[9] M. Ozaki,et al. Evaluation of liver tumors using fluorine-18-fluorodeoxyglucose PET: characterization of tumor and assessment of effect of treatment. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] Z. Burak,et al. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer , 2006, Annals of nuclear medicine.
[11] E. Hoffman,et al. Noninvasive determination of local cerebral metabolic rate of glucose in man. , 1980, The American journal of physiology.
[12] L M Hamberg,et al. Simplified measurement of deoxyglucose utilization rate. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[13] John A. Swets,et al. Evaluation of diagnostic systems : methods from signal detection theory , 1982 .
[14] R. Hardoff,et al. Uptake of gallium-67 citrate and [2-3H]deoxyglucose in the tumor model, following chemotherapy and radiotherapy. , 1985, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[15] Y. Inoue,et al. Thallium‐201‐chloride thyroid scintigraphy to evaluate benign and/or malignant nodules usefulness of the delayed scan , 1982, Cancer.
[16] D. Mankoff,et al. Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy. , 2002, Academic radiology.
[17] R. Birdwell,et al. Potential of Dual-Time-Point Imaging to Improve Breast Cancer Diagnosis with 18F-FDG PETKumar R, Loving VA, Chauhan A, et al (Univ of Pennsylvania, Philadelphia) J Nucl Med 46:1819–1824, 2005§ , 2007 .
[18] V. Clark,et al. Computer-aided multivariate analysis , 1991 .
[19] T. A. Smith,et al. FDG uptake, tumour characteristics and response to therapy: A review , 1998, Nuclear medicine communications.
[20] Thomas K Lewellen,et al. 18F-FDG PET of gliomas at delayed intervals: improved distinction between tumor and normal gray matter. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] K. Herholz,et al. Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group. , 1999, European journal of cancer.